1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Ultrasonic Nebulizers Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Ultrasonic Nebulizers Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Technological Advancements
5.2. Disease Prevalence & Incidence Rate Globally With Key Countries
5.3. Key Size/Brand Analysis
5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Ultrasonic Nebulizers Market Analysis and Forecast, by Size
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Size, 2017–2031
6.3.1. Small-volume Ultrasonic Nebulizer
6.3.2. Large-volume Ultrasonic Nebulizer
6.4. Market Attractiveness Analysis, by Size
7. Global Ultrasonic Nebulizers Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Chronic Obstructive Pulmonary Disease (COPD)
7.3.2. Asthma
7.3.3. Cystic Fibrosis
7.3.4. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Ultrasonic Nebulizers Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Specialty Clinics
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Ultrasonic Nebulizers Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Ultrasonic Nebulizers Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Size, 2017–2031
10.2.1. Small-volume Ultrasonic Nebulizer
10.2.2. Large-volume Ultrasonic Nebulizer
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Chronic Obstructive Pulmonary Disease (COPD)
10.3.2. Asthma
10.3.3. Cystic Fibrosis
10.3.4. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Specialty Clinics
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Size
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Ultrasonic Nebulizers Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Size, 2017–2031
11.2.1. Small-volume Ultrasonic Nebulizer
11.2.2. Large-volume Ultrasonic Nebulizer
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Chronic Obstructive Pulmonary Disease (COPD)
11.3.2. Asthma
11.3.3. Cystic Fibrosis
11.3.4. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Specialty Clinics
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Size
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Ultrasonic Nebulizers Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Size, 2017–2031
12.2.1. Small-volume Ultrasonic Nebulizer
12.2.2. Large-volume Ultrasonic Nebulizer
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Chronic Obstructive Pulmonary Disease (COPD)
12.3.2. Asthma
12.3.3. Cystic Fibrosis
12.3.4. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Specialty Clinics
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Size
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Ultrasonic Nebulizers Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Size, 2017–2031
13.2.1. Small-volume Ultrasonic Nebulizer
13.2.2. Large-volume Ultrasonic Nebulizer
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Chronic Obstructive Pulmonary Disease (COPD)
13.3.2. Asthma
13.3.3. Cystic Fibrosis
13.3.4. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Specialty Clinics
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Size
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Ultrasonic Nebulizers Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Size, 2017–2031
14.2.1. Small-volume Ultrasonic Nebulizer
14.2.2. Large-volume Ultrasonic Nebulizer
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Chronic Obstructive Pulmonary Disease (COPD)
14.3.2. Asthma
14.3.3. Cystic Fibrosis
14.3.4. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Specialty Clinics
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Size
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Company Profiles
15.3.1. Koninklijke Philips N.V
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Size Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. OMRON Healthcare, Inc.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Size Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Drive Medical
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Size Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Invacare Corporation
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Size Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Medline Industries
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Size Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.6. Agilent Technologies, Inc.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Size Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.7. Inspired Medical
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Size Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.8. Mercury Medical
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Size Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.9. Besmed
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Size Portfolio
15.3.9.3. Financial Overview
15.3.10. AireHealth
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Size Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
Table 01: Global Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Size, 2017–2031
Table 02: Global Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 03: Global Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Size, 2017–2031
Table 07: North America Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 08: North America Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Size, 2017–2031
Table 11: Europe Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 12: Europe Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Size, 2017–2031
Table 15: Asia Pacific Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 16: Asia Pacific Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Size, 2017–2031
Table 19: Latin America Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 20: Latin America Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Size, 2017–2031
Table 23: Middle East & Africa Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 24: Middle East & Africa Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/